ekonominyheter

TranslateRSSMobil
AstraZeneca Forecasts Annual Revenue of $45 Billion by 2023

AstraZeneca Forecasts Annual Revenue of $45 Billion by 2023

Wall Street Journal 18/11 04:24

U.K.-listed pharmaceutical company AstraZeneca said its pipeline of drugs is expected to drive strong and consistent revenue growth, delivering annual revenues in excess of $45 billion by 2023.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status